| 1 |
32734419 | Etest Methods for Screening Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) strains. | 2020 Oct |
1 |
| 2 |
28139739 | Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA. | 2017 Jan 31 |
7 |
| 3 |
26320398 | Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013. | 2016 Oct |
1 |
| 4 |
25699490 | Performance of vancomycin and teicoplanin disk diffusion test in isogenic vancomycin non-susceptible Staphylococcus aureus. | 2015 Feb 19 |
4 |
| 5 |
21976769 | Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States. | 2011 Dec |
1 |
| 6 |
19744978 | Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. | 2009 Nov |
1 |